
EP 123: The ethics of newborn genome screening: Actionable insights and beyond with Holly Peay, Senior Research Scientist at the Research Triangle Institute
The Genetics Podcast
00:00
Panel design: actionable and exploratory results
Holly describes panel one (highly actionable), panel two (less actionable/clinical trials), and optional type 1 diabetes risk.
Play episode from 18:38
Transcript


